logo

Carlisle Companies Inc. (CSL)



Trade CSL now with
  Date
  Headline
12/15/2021 7:35:32 AM CSL Behring Gets Accelerated CHMP Assessment For Etranacogene Dezaparvovec For Patients Living With Hemophilia B
12/15/2021 7:34:13 AM EMA Grants Accelerated Assessment For CSL Behring's Haemophilia B Gene Therapy
11/23/2021 8:35:53 AM Seqirus : FDA Approves Multi-Dose Vial Presentation Of Adjuvanted, Cell-Based Pandemic Influenza Vaccine
11/1/2021 4:33:24 PM Carlisle Companies Declares Quarterly Dividend Of $0.54/share, Payable Dec. 1/ Record Nov. 17
10/21/2021 4:14:35 PM Carlisle Companies Q3 EPS $2.67 Vs. $1.87 Year Ago
10/18/2021 9:58:57 PM CSL Says Advances Novel Pipeline Spanning Six Therapeutic Areas, Four Scientific Platforms And Two Businesses
10/4/2021 8:04:37 AM Seqirus Receives Multi-year, $34.95 Mln U.S. Govt. Contract To Develop Two Pandemic Influenza Vaccines
9/9/2021 8:36:20 AM CSL's Global Chief Human Resources Officer Elizabeth Walker Appointed To Urban League Of Philadelphia's Board
9/1/2021 4:09:19 PM Carlisle Companies Completes Purchase Of Henry Company
8/26/2021 8:08:32 AM CSL Plasma To Provide Influenza Vaccination Vouchers To U.S. Plasma Donors
8/19/2021 8:32:38 AM Seqirus Plans To Accelerate Development Of Next Generation Of Messenger RNA Vaccine Technology
8/3/2021 9:13:00 AM CSL Behring : FDA Approves New BERINERT Administration Kit For Increased Patient Convenience
8/2/2021 4:14:39 PM Carlisle Companies Completes Sale Of Carlisle Brake & Friction
8/2/2021 4:14:22 PM CentroMotion Completes Acquisition Of Carlisle Brake & Friction
7/30/2021 8:32:38 AM Seqirus Presents New Safety Data Demonstrating Safety Of Cell-Based Seasonal Influenza Vaccine On Pregnancy Outcomes